Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-001276
Filing Date
2006-03-01
Accepted
2006-03-01 14:38:34
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. FORM 10-K b59388epe10vk.htm 10-K 736370
2 EX-23.1 CONSENT OF ERNST & YOUNG LLP b59388epexv23w1.htm EX-23.1 1742
3 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b59388epexv31w1.htm EX-31.1 5620
4 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b59388epexv31w2.htm EX-31.2 6135
5 EX-32 SECTION 906 CERTIFICATION OF C.E.O. & C.F.O. b59388epexv32.htm EX-32 3729
  Complete submission text file 0000950135-06-001276.txt   755054
Mailing Address 71 ROGERS ST CAMBRIDGE MA 02142-1118
Business Address 71 ROGERS ST CAMBRIDGE MA 02142-1118 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21863 | Film No.: 06654861
SIC: 2835 In Vitro & In Vivo Diagnostic Substances